Cite
HARVARD Citation
Barth, A. et al. (2023). Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug–drug interactions via CYP3A metabolism and transporters. Clinical and translational science. 16 (4), pp. 647-661. [Online].